| Cannabinoids in health and disease NM Kogan, R Mechoulam Dialogues in clinical neuroscience, 2007 | 336 | 2007 |
| Beyond THC and endocannabinoids P Pacher, NM Kogan, R Mechoulam Annual review of pharmacology and toxicology 60 (1), 637-659, 2020 | 155 | 2020 |
| Synthesis and antitumor activity of quinonoid derivatives of cannabinoids NM Kogan, R Rabinowitz, P Levi, D Gibson, P Sandor, M Schlesinger, ... Journal of Medicinal Chemistry 47 (15), 3800-3806, 2004 | 128 | 2004 |
| Cannabidiol, a major non‐psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts NM Kogan, E Melamed, E Wasserman, B Raphael, A Breuer, KS Stok, ... Journal of Bone and Mineral Research 30 (10), 1905-1913, 2015 | 118 | 2015 |
| The chemistry of endocannabinoids NM Kogan, R Mechoulam Journal of endocrinological investigation 29 (3), 3, 2006 | 108 | 2006 |
| A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells NM Kogan, C Blazquez, L Alvarez, R Gallily, M Schlesinger, M Guzman, ... Molecular pharmacology 70 (1), 51-59, 2006 | 89 | 2006 |
| HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor NM Kogan, M Schlesinger, E Priel, R Rabinowitz, E Berenshtein, ... Molecular Cancer Therapeutics 6 (1), 173-183, 2007 | 82 | 2007 |
| Cannabinoids and cancer NM Kogan Mini reviews in medicinal chemistry 5 (10), 941-952, 2005 | 79 | 2005 |
| CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency R Smoum, S Baraghithy, M Chourasia, A Breuer, N Mussai, ... Proceedings of the National Academy of Sciences 112 (28), 8774-8779, 2015 | 64 | 2015 |
| Concise review: energy metabolites: key mediators of the epigenetic state of pluripotency A Moussaieff, NM Kogan, D Aberdam Stem Cells 33 (8), 2374-2380, 2015 | 56 | 2015 |
| A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study NM Kogan, M Schlesinger, M Peters, G Marincheva, R Beeri, ... Journal of Pharmacology and Experimental Therapeutics 322 (2), 646-653, 2007 | 51 | 2007 |
| Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments T Ben-Gedalya, R Lyakhovetsky, Y Yedidia, M Bejerano-Sagie, ... Journal of cell science 124 (11), 1891-1902, 2011 | 38 | 2011 |
| HU-444, a novel, potent anti-inflammatory, nonpsychotropic cannabinoid CG Haj, PF Sumariwalla, L Hanuš, NM Kogan, Z Yektin, R Mechoulam, ... Journal of Pharmacology and Experimental Therapeutics 355 (1), 66-75, 2015 | 30 | 2015 |
| HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity M Peters, NM Kogan Expert Opinion on Investigational Drugs 16 (9), 1405-1413, 2007 | 22 | 2007 |
| Novel CBG derivatives can reduce inflammation, pain and obesity NM Kogan, Y Lavi, LM Topping, RO Williams, FE McCann, Z Yekhtin, ... Molecules 26 (18), 5601, 2021 | 20 | 2021 |
| Cannabinoid quinones—A review and novel observations NM Kogan, M Peters, R Mechoulam Molecules 26 (6), 1761, 2021 | 20 | 2021 |
| A shift in glycerolipid metabolism defines the follicular fluid of IVF patients with unexplained infertility A Batushansky, A Zacharia, A Shehadeh, R Bruck-Haimson, ... Biomolecules 10 (8), 1135, 2020 | 14 | 2020 |
| Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans A Zacharia, D Saidemberg, CT Mannully, NM Kogan, A Shehadeh, ... The American Journal of Clinical Nutrition 112 (4), 979-990, 2020 | 10 | 2020 |
| Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2 B Raphael-Mizrahi, M Attar-Namdar, M Chourasia, MG Cascio, A Shurki, ... Elife 11, e65834, 2022 | 9 | 2022 |
| Novel cannabidiol derivatives and their use as anti-inflammatory agents R Mechoulam, N Kogan, R Gallily, A Breuer | 8 | 2008 |
